Merida Biosciences Launches with $121M to Create Therapeutics for Multiple Autoimmune and Allergic Diseases
 

MOMA Therapeutics Appoints Susan Pandya, M.D., to Board of Directors and Expands Management Team
 

Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights
 

Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial Results

CARGO Therapeutics Provides Corporate Update